Last edition
News about "Oncology Pipeline"
Bristol Myers Squibb and Hengrui Pharma collaborated to jointly develop 13 early-stage programmes across oncology, haematology and immunology, with a potential deal value of up to USD 15.2 billion.
Oncology Pipeline | 13/05/2026 | By News Bureau
Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline
Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.
Oncology Pipeline | 06/05/2026 | By News Bureau
Merck & Co. is reportedly nearing a USD 6 billion acquisition of Terns Pharmaceuticals, as part of its strategy to strengthen its oncology portfolio and prepare for future growth.
Oncology Pipeline | 25/03/2026 | By Darshana | 127
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy